Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering

Bibliography

• Langer R, Vacanti J. Tissue engineering. Science 1993;260:920-6
   PubMed Web of Science ®Google Scholar
• Freed L, Vunjak-Novakovic G, Biron R, et al. Biodegradable polymer scaffolds for tissue engineering. Nat Biotechnol 1994;12:689-93
   Web of Science ®Google Scholar
• Bonassar J, Vacanti C. Tissue engineering: the first decade and beyond. J Cell Biochem Suppl 1998;30:297-303
   PubMedGoogle Scholar
• Shea L, Smiley E, Bonadio J, et al. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999;17:551-4
   PubMed Web of Science ®Google Scholar
• Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000;21:2529-43
   PubMed Web of Science ®Google Scholar
• Hoffman A. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002;43:3-12
   Web of Science ®Google Scholar
• Powers MJ, Domansky K, Kaazempur-Mofrad MR, et al. A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng 2002;78:257-69
   PubMed Web of Science ®Google Scholar
• Rezwan K, Chen QZ, Blaker JJ, et al. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006;27:3413-31
   PubMed Web of Science ®Google Scholar
• Guarino V, Gloria A, Raucci M, et al. Bio-inspired composite and cell instructive platforms for bone regeneration. Int Mater Rev 2012;57:256-75
   Web of Science ®Google Scholar
• Garg T, Singh O, Arora S, et al. Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 2012;29:1-63
   PubMed Web of Science ®Google Scholar
• Gravel M, Gross T, Vago R, et al. Responses of mesenchymal stem cell to chitosan-coralline composites microstructured using coralline as gas forming agent. Biomaterials 2006;27:1899-906
   PubMed Web of Science ®Google Scholar
• Lee SH, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 2007;59:339-59
   PubMed Web of Science ®Google Scholar
• Cipitria A, Lange C, Schell H, et al. Porous scaffold architecture guides tissue formation. J Bone Mineral Res 2012;27:1275-88
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Annabi M, Nikkhah M, et al. Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng B Rev 2012;18:363-82
   PubMed Web of Science ®Google Scholar
• Blackwood K, Bock N, Dargaville Y, et al. Scaffolds for growth factor delivery as applied to bone tissue engineering. Int J Polym Sci 2012;2012:174942
   Web of Science ®Google Scholar
• Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 2008;60:184-98
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Gelinsky M, Kawasaki T, et al. Biomimetic porous scaffolds with high elasticity made from mineralized collagen. An animal study. J Biomed Mater Res 2005;75B:464-72
   Web of Science ®Google Scholar
• Salvay DM, Shea LD. Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol Biosystems 2006;2:36-48
   PubMed Web of Science ®Google Scholar
• Biondi M, Ungaro F, Quaglia F, et al. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 2008;60:229-42
   PubMed Web of Science ®Google Scholar
• Sabir MI, Xu X, Li L. A review on biodegradable polymeric materials for bone tissue engineering applications. J Mater Sci 2009;44:5713-24
   Web of Science ®Google Scholar
• Baroli B. From natural bone graft to tissue engineering therapeutics: brainstorming on pharmaceutical formulative requirements and challenges. J Pharm Sci 2009;98:1317-75
   PubMed Web of Science ®Google Scholar
• Mouriño V, Boccaccini AR. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface 2010;7:209-27
   PubMed Web of Science ®Google Scholar
• Wende J, Guelcher S. Dual delivery of an antibiotic and a growth factor addresses both the microbiological and biological challenges of contaminated bone fractures. Expert Opin Drug Deliv 2011;8:1555-69
   PubMed Web of Science ®Google Scholar
• Vo T, Kasper F, Mikos A. Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev 2012;64:1292-309
   PubMed Web of Science ®Google Scholar
• Ekenseair A, Kasper F, Mikos A. Perspectives on the interface of drug delivery and tissue engineering. Adv Drug Deliv Rev 2013;65:89-92
   PubMed Web of Science ®Google Scholar
• Lee H-J, Ahn S-H, Kim GH. Three-dimensional collagen/alginate hybrid scaffolds functionalized with a Drug Delivery System (DDS) for bone tissue regeneration. Chem Mater 2012;24:881-91
   Web of Science ®Google Scholar
• Kolambkar YM, Dupont KM, Boerckel JD, et al. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 2011;32:65-74
   PubMed Web of Science ®Google Scholar
• Furth ME, Atala A, van Dyke ME. Smart biomaterials design for tissue engineering and regenerative medicine. Biomaterials 2007;28:5068-73
   PubMed Web of Science ®Google Scholar
• Liu Y, Lim J, Teoh S. Review: development of clinically relevant scaffolds for vascularised bone tissue engineering. Biotechnol Adv 2012;S0734-9750(12):00184-X
   Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76
   PubMed Web of Science ®Google Scholar
• Inada M, Katagiri T, Akiyama S, et al. Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts. Biochem Biophys Res Commun 1996;222:317-22
   PubMed Web of Science ®Google Scholar
• Katagiri T, Yamaguchi A, Komaki M. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblats into the osteoblastic lineage. J Cell Biology 1994;127:1755-66
   PubMed Web of Science ®Google Scholar
• Chung HJ, Park TG. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev 2007;59:249-62
   PubMed Web of Science ®Google Scholar
• Somayaji BV, Jariwala U, Jayachandran P, et al. Evaluation of antimicrobial efficacy and release pattern of tetracycline and metronidazole using a local delivery system. J Periodontol 1998;69:409-13
   PubMed Web of Science ®Google Scholar
• Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987;237:1588-95
   PubMed Web of Science ®Google Scholar
• Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev 2006;35:780-9
   PubMed Web of Science ®Google Scholar
• Zilberman M, Elsner J. Antibiotic-eluting medical devices for various applications. J Control Release 2008;130:202-15
   PubMed Web of Science ®Google Scholar
• Gomes ME, Reis RL. Biodegradable polymers and composites in biomedical applications from catgut to tissue engineering. Part II: systems for temporary replacement and advanced tissue regeneration. Int Mater Rev 2004;49:274-85
   Web of Science ®Google Scholar
• Habraken WJ, Wolke JG, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:234-48
   PubMed Web of Science ®Google Scholar
• Duarte AR, Simplicio AL, Vega-González A, et al. Supercritical fluid impregnation of a biocompatible polymer for ophthalmic drug delivery. J Supercrit Fluids 2007;42:373-7
   Web of Science ®Google Scholar
• Tampieri A, Landi E, Valentini F, et al. A conceptually new type of bio-hybrid scaffold for bone regeneration. Nanotechnology 2011;22:015104
   Web of Science ®Google Scholar
• Tampieri A, Celotti G, Landi E, et al. Biologically inspired synthesis of bone-like composite: self-assembled collagen fibers/hydroxyapatite nanocrystals. J Biomed Mater Res 2003;67A:618-25
   Web of Science ®Google Scholar
• Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005;5:675-88
   PubMed Web of Science ®Google Scholar
• Kreeger PK, Deck JW, Woodruff TK, et al. The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials 2006;27:714-23
   PubMed Web of Science ®Google Scholar
• Weaver VM, Fischer AH, Peterson OW, et al. The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem Cell Biol 1996;74:833-51
   PubMed Web of Science ®Google Scholar
• De Laporte L, Shea LD. Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:292-307
   PubMed Web of Science ®Google Scholar
• Guarino V, Causa F, Ambrosio L. Bioactive scaffolds for bone and ligament tissue. Exp Rev Med Devices 2007;4:405-18
   PubMed Web of Science ®Google Scholar
• Saltzman WM, Olbricht WL. Building drug delivery into tissue engineering. Nat Rev Drug Discov 2002;1:177-86
   PubMed Web of Science ®Google Scholar
• Baker RW. Controlled release of biologically active agents. Wiley; New York: 1987
   Google Scholar
• Chasin M, Langer R. Biodegradable polymers as drug delivery systems. Marcel Dekker; New York: 1990
   Google Scholar
• Flynn GL, Yalkowski SH, Roseman TJ. Mass transfer phenomena and models: theoretical concepts. J Pharm Sci 1974;63:479-510
   PubMed Web of Science ®Google Scholar
• Kim CJ. Controlled release dosage form design. Technomic; Lancaster, PA: 1999
   Google Scholar
• Langer R. Drug delivery and targeting. Nature 1998;392:5-10
   PubMed Web of Science ®Google Scholar
• Rathbone MJ, Hadgraft J, Roberts MS. editors. Modified-release drug delivery technology. Marcel Dekker; New York: 2003
   Google Scholar
• Uchegbu IF, Schatzlein AG. editors. Polymers in drug delivery. Taylor and Francis; Boca Raton, FL: 2008
   Google Scholar
• Hafeman A, Zienkiewicz K, Carney E, et al. Local delivery of tobramycin from injectable biodegradable polyurethane scaffolds. J Biomater Sci Polym Ed 2010;21:95-112
   PubMed Web of Science ®Google Scholar
• Sun B, Ma W, Su F, et al. The osteogenic differentiation of dog bone marrow mesenchymal stem cells in a thermo-sensitive injectable chitosan/collagen/beta-glycerophosphate hydrogel: in vitro and in vivo. J Mater Sci Mater Med 2011;22:2111-18
   PubMed Web of Science ®Google Scholar
• Catledge SA, Vohra YK, Bellis SL, et al. Mesenchymal stem cell adhesion and spreading on nanostructured biomaterials. J Nanosci Nanotechnol 2004;4:986-9
   PubMed Web of Science ®Google Scholar
• Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 2004;32:477-86
   PubMed Web of Science ®Google Scholar
• Best SM, Porter AE, Thian ES, et al. Bioceramics: past, present and for the future. J Eur Ceram Soc 2008;28:1319-27
   Web of Science ®Google Scholar
• Zhang K, Wang Y, Hillmyer MA, et al. Processing and properties of porous poly(L-lactide)/bioactive glass composites. Biomaterials 2004;25:2489-500
   PubMed Web of Science ®Google Scholar
• Lu HH, Tang A, Oh SC, et al. Compositional effects on the formation of a calcium phosphate layer and the response of osteoblast-like cells on polymer-bioactive glass composites. Biomaterials 2005;26:6323-34
   PubMed Web of Science ®Google Scholar
• Jiang G, Evans ME, Jones IA, et al. Preparation of poly(epsilon-caprolactone)/continuous bioglass fibre composite using monomer transfer moulding for bone implant. Biomaterials 2005;26:2281-8
   PubMed Web of Science ®Google Scholar
• Kim SS, Park MS, Gwak SJ, et al. Accelerated bonelike apatite growth on porous polymer/ceramic composite scaffolds in vitro. Tissue Eng 2006;12:2997-3006
   PubMedGoogle Scholar
• Rice MA, Dodson BT, Arthur JA, et al. Cell-based therapies and tissue engineering. Otolaryngol Clin North Am 2005;38:199-214
   PubMed Web of Science ®Google Scholar
• Meinel L, Fajardo R, Hofmann S, et al. Silk implants for the healing of critical size bone defects. Bone 2005;37:688-98
   PubMed Web of Science ®Google Scholar
• Huang L, Hu J, Lang L, et al. Synthesis and characterization of electroactive and biodegradable ABA block copolymer of polylactide and aniline pentamer. Biomaterials 2007;28:1741-51
   PubMed Web of Science ®Google Scholar
• Angelopoulou A, Efthimiadou EK, Kordas G. Dextran modified pH sensitive silica hydro-xerogels as promising drug delivery scaffolds. Mater Lett 2012;74:50-3
   Web of Science ®Google Scholar
• Temtem M, Barroso T, Casimiro T, et al. Dual stimuli responsive poly(N-isopropylacrylamide) coated chitosan scaffolds for controlled release prepared from a non residue technology. J Supercritical Fluids 2012;66:398-404
   Web of Science ®Google Scholar
• Boccaccini AR, Erol M, Stark MJ, et al. Polymer/bioactive glass nanocomposites for biomedical applications. A Review. Compos Sci Technol 2010;70:1764-76
   Web of Science ®Google Scholar
• Webster TJ, Ergun C, Doremus RH, et al. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 2000;21:1803-10
   PubMed Web of Science ®Google Scholar
• Wei G, Ma PX. Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials 2004;25:4749-57
   PubMed Web of Science ®Google Scholar
• Wu C, Miron R, Sculean A, et al. Proliferation, differentiation and gene expression of osteoblasts in boron-containing mesoporous bioactive glass scaffolds with sustained dexamethasone delivery. Biomaterials 2011;32:7068-78
   PubMed Web of Science ®Google Scholar
• Vallet-Regí M, Balas F, Colilla M, et al. Bone-regenerative bioceramic implants with drug and protein controlled delivery capability. Prog Solid State Chem 2008;36:163-91
   Web of Science ®Google Scholar
• Hum J, Boccaccini AR. Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review. J Mater Sci Mater Med 2012;23:2317-33
   PubMed Web of Science ®Google Scholar
• Hutmacher DW, Schantz JT, Lam CXF, et al. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 2007;1:245-60
   PubMed Web of Science ®Google Scholar
• Wang H, Li Y, Zuo Y, et al. Biocompatibility and osteogenesis of biomimetic nanohydroxyapatite/polyamide composite scaffolds for bone tissue engineering. Biomaterials 2007;28:3338-48
   PubMed Web of Science ®Google Scholar
• Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater 2005;4:518-24
   PubMed Web of Science ®Google Scholar
• Derby B. Printing and prototyping of tissues and scaffolds. Science 2012;338:921-6
   PubMed Web of Science ®Google Scholar
• Ovsianikov A, Mironov V, Stampfl J, et al. Engineering 3D cell-culture matrices: multiphoton processing technologies for biological and tissue engineering applications. Exp Rev Med Devices 2012;9:613-63
   PubMed Web of Science ®Google Scholar
• Kim H, Kim HW, Suh H. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. Biomaterials 2003;24:4671-9
   PubMed Web of Science ®Google Scholar
• Bonadio J, Smiley E, Patil P, et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999;5:753-9
   PubMed Web of Science ®Google Scholar
• Kim H, Knowles J, Kim H. Hydroxyapatite/poly(ε-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 2004;25:1279-87
   PubMed Web of Science ®Google Scholar
• Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011;11:471-91
   PubMed Web of Science ®Google Scholar
• Cook AD, Hrkach JS, Gao NN, et al. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J Biomed Mater Res 1997;35:513-23
   PubMed Web of Science ®Google Scholar
• Sakiyama-Elbert SE, Panitch A, Hubbell JA. Development of growth factor fusion proteins for celltriggered drug delivery. FASEB J 2001;15:1300-2
   PubMed Web of Science ®Google Scholar
• Harris LD, Kim B, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998;42:396-402
   PubMed Web of Science ®Google Scholar
• Mooney DJ, Baldwin DF, Suh NP, et al. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 1996;17:1417-22
   PubMed Web of Science ®Google Scholar
• Heyde M, Partridge KA, Howdle SM, et al. Development of a controlled non-viral DNA release system from PDLLA scaffolds fabricated using a supercritical CO2 technique. Biotechnol Bioeng 2007;98:679-93
   PubMed Web of Science ®Google Scholar
• Li W, Laurencin CT, Caterson EJ, et al. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 2002;60:613-21
   PubMed Web of Science ®Google Scholar
• Matthews JA, Wnek GE, Simpson DG, et al. Electrospinning of collagen nanofibers. Biomacromolecules 2002;3:232-8
   PubMed Web of Science ®Google Scholar
• Sanders EH, Kloefkorn R, Bowlin GL, et al. Two-phase electrospinning from a single electrified jet: microencapsulation of aqueous reservoirs in poly(ethylene-co-vinyl acetate) fibers. Macromolecules 2003;36:3803-5
   Web of Science ®Google Scholar
• Ma PX. Tissue Engineering. In: Kroschwitz JI, editor. Encyclopedia of Polymer Science and Technology. Third. Vol. 12, John Wiley & Sons, Inc; Hoboken, NJ: 2005. p. 261-91
   Google Scholar
• Gupta A, Seifalian AM, Edirisinghe MJ, et al. Novel Electrohydrodynamic printing of nanocomposite biopolymer scaffolds. J Bioact Comp Polym 2007;22:265-80
   Web of Science ®Google Scholar
• Enayati M, Ahmad Z, Stride E, et al. One-step electrohydrodynamic production of drug-loaded micro- and nanoparticles. J R Soc Interface 2010;7:667-75
   PubMed Web of Science ®Google Scholar
• Jiang H, Hu Y, Li Y, et al. A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. J Control Release 2005;108:237-43
   PubMed Web of Science ®Google Scholar
• Liao IC, Chew SY, Leong KW. Aligned core-shell nanofibers delivering bioactive proteins. Nanomedicine 2006;1:465-71
   PubMed Web of Science ®Google Scholar
• Bock N, Woodruff MA, Hutmacher DW, et al. Electrospraying, a reproducible method for production of polymeric microspheres for biomedical applications. Polymers 2011;3:131-49
   Web of Science ®Google Scholar
• Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog 2009;25:1539-60
   PubMed Web of Science ®Google Scholar
• Woodruff MA, Lange L, Reichert J, et al. Bone tissue engineering: from bench to bedside. Mater Today 2012;15:430-5
   Web of Science ®Google Scholar
• Kim HW, Knowles JC, Kim HE. Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release. J Mater Sci Mater Med 2005;16:189-95
   PubMed Web of Science ®Google Scholar
• Francis L, Meng D, Knowles J, et al. Multi-functional P(3HB) microsphere/45S5 bioglass-based composite scaffolds for bone tissue engineering. Acta Biomater 6:2010;2773-86
   PubMed Web of Science ®Google Scholar
• Chaisri W, Ghassemi AH, Hennink WE, et al. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Colloid Surf B 2011;84:508-14
   PubMed Web of Science ®Google Scholar
• Ungaro F, Biondi M, d’Angelo I, et al. Microsphereintegrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics. J Control Release 2006;113:128-36
   PubMed Web of Science ®Google Scholar
• Schnieders J, Gbureck U, Vorndran E, et al. The effect of porosity on drug release kinetics from vancomycin microsphere/calcium phosphate cement composites. J Biomed Mater Res B 2011;99:391-8
   Google Scholar
• Dos Santos DF, Bitencourt CS, Gelfuso GM, et al. Biodegradable microspheres containing leukotriene B4 and cellfree antigens from histoplasma capsulatum activate murine bone marrow-derived macrophages. Eur J Pharm Sci 2011;44:580-8
   PubMed Web of Science ®Google Scholar
• De Laporte L, des Rieux A, Tuinstra H, et al. Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury. J Biomed Mater Res A 2011;98:372-82
   PubMedGoogle Scholar
• Lee S-H, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 2007;59:339-59
   PubMed Web of Science ®Google Scholar
• Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005;16:329-45
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang Q, Wang A. In situ generation of sodium alginate/hydroxyapatite nanocomposite beads as drug-controlled release matrices. Acta Biomater 2010;6:445-54
   PubMed Web of Science ®Google Scholar
• Lee SY, Kim HU, Park JH, et al. Metabolic engineering of microorganisms: general strategies and drug production. Drug Discov Today 2009;14:78-88
   PubMedGoogle Scholar
• Escarlata RC, Villaverd A. Nanostructured bacterial materials for innovative medicines. Trends Microbiol 2010;18:423-30
   PubMed Web of Science ®Google Scholar
• Misra SK, Nazhat SN, Valappil SP, et al. Fabrication and characterization of biodegradable poly(3-hydroxybutyrate) composite containing bioglass. Biomacromolecules 2007;8:2112-19
   PubMed Web of Science ®Google Scholar
• Valappil SP, Misra SK, Boccaccini AR, et al. Large-scale production and efficient recovery of PHB with desirable material properties, from the newly characterised Bacillus cereus SPV. J Biotechnol 2007;132:251-8
   PubMed Web of Science ®Google Scholar
• Jung P, Kim KC, Park HK, et al. Spontaneous liberation of intracellular polyhydroxybutyrate granules in Escherichiacoli. Res Microbiol 2005;156:865-73
   PubMed Web of Science ®Google Scholar
• Yu L, Dean K, Li L. Polymer blends and composites from renewable resources. Prog Polym Sci 2006;31:576-602
   Web of Science ®Google Scholar
• Mouriño V, Newby P, Pishbin F, et al. Physicochemical, biological and drug-release properties of gallium crosslinked alginate/nanoparticulate bioactive glass composite films. Soft Matter 2011;7:6705-12
   Web of Science ®Google Scholar
• Hoppe A, Güldal NS, Boccaccini AR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 2011;32:2757-74
   PubMed Web of Science ®Google Scholar
• Habibovic P, Barralet JE. Bioinorganics and biomaterials: bone repair. Acta Biomater 2011;7:3013-26
   PubMed Web of Science ®Google Scholar
• Mouriño V, Cattalini JP, Boccaccini AR. Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments. J R Soc Interface 2012;9:401-19
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang M. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. J Biomed Mater Res 2002;62:378-86
   PubMed Web of Science ®Google Scholar
• Teng S-H, Lee E-J, Wang P, et al. Functionally gradient chitosan/hydroxyapatite composite scaffolds for controlled drug release. J Biomed Mater Res 2009;90B:275-82
   Web of Science ®Google Scholar
• Cabañas MV, Peña J, Román J, et al. Tailoring vancomycin release from beta-TCP/agarose scaffolds. Eur J Pharm Sci 2009;37:249-56
   PubMed Web of Science ®Google Scholar
• Zhou J, Fang T, Wang Y, et al. The controlled release of vancomycin in gelatin/beta-TCP composite scaffolds. J Biomed Mater Res 2012;100A:2295-01
   Web of Science ®Google Scholar
• Duarte ARC, Mano JF, Reis RL. Dexamethasone-loaded scaffolds prepared by supercritical-assisted phase inversion. Acta Biomater 2009;5:2054-62
   PubMed Web of Science ®Google Scholar
• Kale S, Biermann S, Edwards C. Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol 2000;18:954-8
   PubMed Web of Science ®Google Scholar
• Nie H, Beng WS, Fu YC, et al. Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol Bioeng 2008;99:223-34
   PubMed Web of Science ®Google Scholar
• Fu YC, Nie H, Ho ML, et al. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2. Biotechnol Bioeng 2008;99:996-1006
   PubMed Web of Science ®Google Scholar
• Sotoudeh S, Barati A, Davarnejad R, et al. Antibiotic release process from hydrogel nano zeolite composites. Middle East J Sci Research 2012;12:392-6
   Google Scholar
• Liu H, Zhang L, Shi P, et al. Hydroxyapatite/polyurethane scaffold incorporated with drug-loaded ethyl cellulose microspheres for bone regeneration. J Biomed Mater Res B Appl Biomater 2010;95:36-46
   PubMed Web of Science ®Google Scholar
• Castro C, Évora C, Baro M, et al. Two-month ciprofloxacin implants for multibacterial bone infections. Eur J Pharm Sci 2005;60:401-6
   Google Scholar
• Shi M, Kretlow J, Nguyen A, et al. Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control. Biomaterials 2010;31:4146-56
   PubMed Web of Science ®Google Scholar
• Miyai T, Ito A, Tamazawa G, et al. Antibiotic-loaded poly-e-caprolactone and porous beta-tricalcium phosphate composite for treating osteomyelitis. Biomaterials 2008;29:350-8
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang D, Chen H, et al. An ionically crosslinked hydrogel containing vancomycin coating on a porous scaffold for drug delivery and cell culture. Int J Pharm 2008;353:74-87
   PubMed Web of Science ®Google Scholar
• Chen M, Le D, Hein S, et al. Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release. Int J Nanomedicine 2012;7:4285-97
   PubMed Web of Science ®Google Scholar
• Son J, Appleford M, Ong J, et al. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres. J Control Release 2011;153:133-40
   PubMed Web of Science ®Google Scholar
• Mortera R, Onida B, Fiorilli S, et al. Synthesis and characterization of MCM-41 spheres inside bioactive glass–ceramic scaffold. Chem Eng J 2008;137:54-61
   Web of Science ®Google Scholar
• Puppi D, Piras A, Chiellini F, et al. Optimized electro- and wet-spinning techniques for the production of polymeric fibrous scaffolds loaded with bisphosphonate and hydroxyapatite. J Tissue Eng Regen Med 2011;5:253-63
   PubMed Web of Science ®Google Scholar
• Wang Y, Shi X, Ren L, et al. In vitro osteogenesis of synovium mesenchymal cells induced by controlled release of alendronate and dexamethasone from a sintered microspherical scaffold. J Biomater Sci Polym Ed 2010;21:1227–38
   PubMed Web of Science ®Google Scholar
• Mondal T, Sunny MC, Khastgir D, et al. Poly (L-lactide-co-epsilon caprolactone) microspheres laden with bioactive glass-ceramic and alendronate sodium as bone regenerative scaffolds. Mater Sci Eng C 2012;32:697-706
   Web of Science ®Google Scholar
• Medvecký L, Štulajterová R, Briančin J. Study of controlled tetracycline release from porous calcium phosphate/polyhydroxybutyrate composites. Chemical Papers 2007;61:477-84
   Web of Science ®Google Scholar